Skip to content

Evaluation of the Effect of Hydration About Orthostatic Hypotension in the Elderly. Difference With Venous Compression

Evaluation of the Effect of Hydration About Orthostatic Hypotension in the Elderly. Difference With Venous Compression. A Randomized Controlled Crossover Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02179216
Acronym
CHHO
Enrollment
110
Registered
2014-07-01
Start date
2014-07-31
Completion date
2016-06-30
Last updated
2015-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthostatic Hypotension

Keywords

Orthostatic hypotension in the elderly, Efficacity of Hydration, Difference between hydratation and venous contention

Brief summary

Primary objective: To compare the decrease in systolic blood pressure between hydration and venous contention when switching to a standing position. Hypothesis in that hydration is better than venous contention. Secondary objective: To evaluate the effect of hydration on lowering systolic blood pressure during the passage standing in elderly patients with orthostatic hypotension. Inclusion criteria: Patient aged over 75 years old with orthostatic hypotension proved to 1 and / or 3 min

Detailed description

Day 0: confirmation of the orthostatic hypotension, without prevented measures Two groups randomized : * Group 1: First day (day 1), Orthostatic Hypotension test after hydration by three large glasses of clear liquid (33cl). Second day (day 2), Orthostatic Hypotension test with venous contention in the morning. * Group 2: First day (day 1), Orthostatic Hypotension test after implementation of venous contention in the morning. Second day (day 2), Orthostatic Hypotension after hydration by three large glasses of clear liquid (33cl).

Interventions

OTHERHydration

Hydratation the first day in the arm 1 Hydration the second day in the arm 2

OTHERVenous contention

Venous contention the second day in the arm 1 Venous contention the first day in the arm 2

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 75 and older with orthostatic hypotension proved to 1 and / or 3 minutes. * Written consent of the subject * Hospitalization or stay expected minimum 3 days * Affiliation to a social security scheme

Exclusion criteria

* bedridden patient or without possibility of verticalization * Patient who can't stand up (pulmonary embolism with high risk) * Patient who refuse to participate in the study * Patient with legal protection * State or condition that may affect the stability of blood pressure during the study (hyperthermia, modification antihypertensive treatments less than 48 hours before inclusion...) * Pathology preventing hydration: Heart failure with less than 1 Liter water restriction, swallowing disorders preventing hydration orally, inability to nutrition and hydration orally * Intravenous or subcutaneous hydration (intravenous or subcutaneous treatments not included) * Patient who can't have venous contention: Blue phlebitis, septic thrombosis, arteritis with score less than 0.6, varicose ulcers during treatment

Design outcomes

Primary

MeasureTime frame
difference in systolic blood pressure between sitting and standing at 1 and 3 minutes between hypotension test with hydration and hypotension test with venous contentionduring 3 days: day 0, day 1, day 2

Secondary

MeasureTime frame
difference in systolic blood pressure between sitting and standing at 1 and 3 minutes between hypotension test with hydration and hypotension test without preventionduring 3 days: at day 0, day 1, day 2

Countries

France

Contacts

Primary ContactAthanase Benetos, Pr
a.benetos@chu-nancy.fr0383153322
Backup ContactMarion Serot Gresser
mariongresser@hotmail.fr0664524831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026